These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 23227456

  • 21. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E, Guntas G, Erdenen F, Akkaya E, Topac I, Irmak H, Derici H, Yavuzer H, Gelisgen R, Uzun H.
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [Abstract] [Full Text] [Related]

  • 22. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients.
    Kumbasar A, Gursu M, Kaya C, Ozturk S, Ergen A, Kemik A, Aydin Z, Uzun S, Karadag S, Kazancioglu R.
    J Nephrol; 2012 Jul; 25(5):825-32. PubMed ID: 22307439
    [Abstract] [Full Text] [Related]

  • 23. Increased Circulating Advanced Oxidation Protein Products and High-Sensitive Troponin T in Cirrhotic Patients with Chronic Hepatitis C: A Preliminary Report.
    Zuwala-Jagiello J, Murawska-Cialowicz E, Pazgan-Simon M.
    Biomed Res Int; 2015 Jul; 2015():786570. PubMed ID: 26665009
    [Abstract] [Full Text] [Related]

  • 24. Oxidative stress markers are increased in patients with mastocytosis.
    Gangemi S, Minciullo PL, Magliacane D, Saitta S, Loffredo S, Saija A, Cristani M, Marone G, Triggiani M.
    Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
    [Abstract] [Full Text] [Related]

  • 25. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T.
    Kidney Blood Press Res; 2004 Apr; 27(2):88-95. PubMed ID: 14739577
    [Abstract] [Full Text] [Related]

  • 26. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG.
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [Abstract] [Full Text] [Related]

  • 27. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
    Rysavá R, Kalousová M, Zima T, Dostál C, Merta M, Tesar V.
    Kidney Blood Press Res; 2007 Feb; 30(1):1-7. PubMed ID: 17191033
    [Abstract] [Full Text] [Related]

  • 28. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF, Sabry S, Nabih M, Elghoroury EA, El-Saaid GS, Ismail AA.
    Ann Nutr Metab; 2009 Feb; 55(4):309-16. PubMed ID: 19828941
    [Abstract] [Full Text] [Related]

  • 29. Oxidative stress markers are increased since early stages of infection in syphilitic patients.
    Hébert-Schuster M, Borderie D, Grange PA, Lemarechal H, Kavian-Tessler N, Batteux F, Dupin N.
    Arch Dermatol Res; 2012 Nov; 304(9):689-97. PubMed ID: 23011658
    [Abstract] [Full Text] [Related]

  • 30. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
    Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C.
    Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
    [Abstract] [Full Text] [Related]

  • 31. Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population.
    Gupta S, Gambhir JK, Kalra O, Gautam A, Shukla K, Mehndiratta M, Agarwal S, Shukla R.
    J Diabetes Complications; 2013 Mar; 27(6):548-52. PubMed ID: 24012111
    [Abstract] [Full Text] [Related]

  • 32. Assessment of ischaemia-modified albumin level in patients with psoriasis.
    Ozdemir M, Kiyici A, Balevi A, Mevlitoğlu I, Peru C.
    Clin Exp Dermatol; 2012 Aug; 37(6):610-4. PubMed ID: 22607558
    [Abstract] [Full Text] [Related]

  • 33. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene.
    Spatari G, Saitta S, Cimino F, Sapienza D, Quattrocchi P, Carrieri M, Barbaro M, Saija A, Gangemi S.
    Int J Hyg Environ Health; 2012 Apr; 215(3):389-92. PubMed ID: 22153878
    [Abstract] [Full Text] [Related]

  • 34. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications.
    Bansal S, Chawla D, Siddarth M, Banerjee BD, Madhu SV, Tripathi AK.
    Clin Biochem; 2013 Jan; 46(1-2):109-14. PubMed ID: 23103709
    [Abstract] [Full Text] [Related]

  • 35. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.
    Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR.
    Clin Biochem; 2009 May; 42(7-8):666-71. PubMed ID: 19318029
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
    Albarello K, dos Santos GA, Bochi GV, Sangoi MB, Almeida TC, Paz da Silva JE, Garcia SC, Moresco RN.
    Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
    [Abstract] [Full Text] [Related]

  • 39. Aging linked to type 2 diabetes increases oxidative stress and chronic inflammation.
    Mendoza-Núñez VM, Rosado-Pérez J, Santiago-Osorio E, Ortiz R, Sánchez-Rodríguez MA, Galván-Duarte RE.
    Rejuvenation Res; 2011 Feb; 14(1):25-31. PubMed ID: 21204649
    [Abstract] [Full Text] [Related]

  • 40. Ischemia modified albumin: an oxidative stress marker in β-thalassemia major.
    Awadallah SM, Atoum MF, Nimer NA, Saleh SA.
    Clin Chim Acta; 2012 May 18; 413(9-10):907-10. PubMed ID: 22336636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.